Pelvic Organ Prolapse Surgery: Long-term Outcomes and Implications for Shared Decision Making

• Autores: Cheryl B. Iglesia
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 309, Nº. 19, 2013, págs. 2045-2046
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Pelvic floor disorders, including pelvic organ prolapse, urinary incontinence, fecal incontinence, and other sensory disorders of the gastrointestinal and genitourinary tract, are common with nearly 1 in 4 US women having at least 1 pelvic floor condition.1 In this issue of JAMA, Nygaard and colleagues2 present findings from the extended Colpopexy and Urinary Reduction Efforts (extended CARE) trial. The original CARE trial3 was a double-blind randomized trial of 322 women mostly with advanced (stage 3-4) prolapse and without stress incontinence symptoms undergoing an open abdominal synthetic mesh sacrocolpopexy procedure either with or without a urethropexy for prevention of stress urinary incontinence.